Related references
Note: Only part of the references are listed.Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study
Adam M. Brickman et al.
ALZHEIMERS & DEMENTIA (2021)
Relationship between brain AD biomarkers and episodic memory performance in healthy aging
Lou Rizzolo et al.
BRAIN AND COGNITION (2021)
Alzheimer's disease
Philip Scheltens et al.
LANCET (2021)
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease
D. O. T. Alawode et al.
JOURNAL OF INTERNAL MEDICINE (2021)
The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics
Lindsay K. Pino et al.
MASS SPECTROMETRY REVIEWS (2020)
Plasma amyloid is associated with the rate of cognitive decline in cognitively normal elderly: the SCIENCe project
Inge M. W. Verberk et al.
NEUROBIOLOGY OF AGING (2020)
CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy
Aurelie Joly-Amado et al.
FRONTIERS IN IMMUNOLOGY (2020)
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline
Axel Montagne et al.
NATURE (2020)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
Sebastian Palmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
IL-8 and MCP-1 Impact on Tau Phosphorylation and Phosphatase Activity
Margarida Vaz et al.
CURRENT ALZHEIMER RESEARCH (2020)
Assessment of Plasma Amyloid-β42/40 and Cognitive Decline Among Community-Dwelling Older Adults
Kelly Virecoulon Giudici et al.
JAMA NETWORK OPEN (2020)
Peripheral inflammatory biomarkers in Alzheimer's disease: a brief review
Jong-Chan Park et al.
BMB REPORTS (2020)
Glial activation and inflammation along the Alzheimer's disease continuum
Kaja Nordengen et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Increases in a Pro-inflammatory Chemokine, MCP-1, Are Related to Decreases in Memory Over Time
Brianne M. Bettcher et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Inflammatory biomarkers in Alzheimer's disease plasma
Angharad R. Morgan et al.
ALZHEIMERS & DEMENTIA (2019)
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Suzanne E. Schindler et al.
NEUROLOGY (2019)
Chemoattraction and Recruitment of Activated Immune Cells, Central Autonomic Control, and Blood Pressure Regulation
Khalid Elsaafien et al.
FRONTIERS IN PHYSIOLOGY (2019)
Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies
Xue-Ning Shen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease
Akio Kimura et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Let's make microglia great again in neurodegenerative disorders
Marie-Victoire Guillot-Sestier et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage
Brianne M. Bettcher et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer's Disease and Mild Cognitive Impairment: A Two-year Follow-up Study
Wei-Ju Lee et al.
SCIENTIFIC REPORTS (2018)
Digit Symbol Substitution Test: The Case for Sensitivity Over Specificity in Neuropsychological Testing
Judith Jaeger
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Association between Hippocampal Shape, Neuroinflammation, and Cognitive Decline in Alzheimer's Disease
Monia Cabinio et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies
Ka Sing P. Lai et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial
Sandrine Andrieu et al.
LANCET NEUROLOGY (2017)
Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis
Vitaliy Ovod et al.
ALZHEIMERS & DEMENTIA (2017)
The Trail Making Test: Association With Other Neuropsychological Measures and Normative Values for Adults Aged 55 Years and Older From a Spanish-Speaking Population-Based Sample
Jordi Llinas-Regla et al.
ASSESSMENT (2017)
Plasma MCP-1 is associated with a faster decline of cognitive function in MCI and dementia due to Alzheimer’s disease
Jong-Ling Fuh et al.
Alzheimers & Dementia (2015)
The CCL2/CCR2 axis enhances IL-6-induced epithelial-mesenchymal transition by cooperatively activating STAT3-Twist signaling
Wei Chen et al.
TUMOR BIOLOGY (2015)
Innate Immune System and Inflammation in Alzheimer's Disease: From Pathogenesis to Treatment
Maria Serpente et al.
NEUROIMMUNOMODULATION (2014)
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
Jan P. Vandenbroucke et al.
INTERNATIONAL JOURNAL OF SURGERY (2014)
Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics
Kwasi G. Mawuenyega et al.
ANALYTICAL BIOCHEMISTRY (2013)
The circulatory systemic environment as a modulator of neurogenesis and brain aging
Saul A. Villeda et al.
AUTOIMMUNITY REVIEWS (2013)
Systemic immune system alterations in early stages of Alzheimer's disease
Rongzhen Zhang et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Amyloid-β-Associated Clinical Decline Occurs Only in the Presence of Elevated P-tau
Rahul S. Desikan et al.
ARCHIVES OF NEUROLOGY (2012)
CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease
Karin Westin et al.
PLOS ONE (2012)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Saul A. Villeda et al.
NATURE (2011)
CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction
Tomomi Kiyota et al.
PLOS ONE (2009)
Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model
Yasumasa Yoshiyama et al.
NEURON (2007)
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease
Daniela Galimberti et al.
NEUROBIOLOGY OF AGING (2006)
Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice
Izumi Maezawa et al.
JOURNAL OF NEUROINFLAMMATION (2006)
Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease
YX Sun et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2003)
Share Paper
